Dr. Willmar Schwabe India has acquired Sanat Products Ltd.
Dr. Willmar Schwabe India, a subsidiary of the German Dr. Willmar Schwabe Group, has acquired Sanat Products Ltd.
Dr. Willmar Schwabe India is engaged in the manufacturing of homeopathic medicines, herbal medicines, specialty formulations and cosmetic products. Dr. Willmar Schwabe Group, based in Germany, is present on five continents. The Schwabe Group comprises several different affiliated companies in the pharmaceutical and health industry. All of the companies within the group focus on plants as the basis for developing their products.
Founded in 1984, Sanat Products Ltd. is a leading manufacturer, supplier and exporter of herbal extracts, ethical products and consumer products. The herbal extracts division (HED) is engaged in the extracting and marketing of standardized herbal extracts to meet the needs of the pharmaceutical, cosmetic, ayurvedic and food industries. The ethical products division (EPD) – prescription-based drugs – offers more than 25 products across a therapeutic mix covering significant chronic and acute segments. These products include dental, oncology, gynecology, diabetes, cardiovascular diseases, dermatology and pain management. The consumer products division (CPD) offers nutraceuticals under brands such as Sunova Bioslim, Sunova Spirulina, Sunova Dr. Shugar, Sunova Curcumin, Uplat and Turmix.
Oaklins’ team in India advised the buyer in this transaction.
Talk to the deal team
Oaklins YES Securities
ScreenPoint Medical has raised US$28 million in a Series C investment round led by Insight Partners
Netherlands-based ScreenPoint Medical, an AI technology company that develops advanced image recognition and machine learning software to improve early detection of breast cancer, has raised US$28 million (€24 million) in a Series C funding round led by New York-based global venture capital and private equity firm Insight Partners to further develop its technology and accelerate commercial growth of the company’s Transpara AI breast care software.Learn more
Intergrin has raised financing provided by Kartesia
Intergrin has obtained a unitranche loan of approximately US$59 million to refinance existing debt and to further support the growth of different healthcare and well-being initiatives.Learn more
MediCA klinika acquires G. Radavičiaus klinika
MediCA klinika has acquired G. Radavičiaus klinika.Learn more